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The incidence of metabolic syndrome and its side effects are increasing
throughout the world. Diet plays a key role in reducing the risk of metabolic syndrome,
possibly mediated by metabolic activity of the gut microbiota. Whole grains (WG) and
fruits and vegetables (FV) are two food groups that are commonly promoted for their
ability to reduce the risk of metabolic syndrome. However, these two food groups
provide vastly different nutrients that likely impact health via different mechanisms.
Therefore, the primary objective of this research was to determine the impact of
consuming recommended amounts of whole grains and fruit and vegetables against a
background of their typical diet on inflammatory makers and gut microbiota composition
in overweight or obese individuals that have low intakes of these food groups. The WG
treatment significantly reduced tumor necrosis factor and lipopolysaccharide binding
protein (TNF-α and LBP), while the FV treatment reduced IL-6 and LBP. Both
treatments induced individualized changes in microbiota composition, with the FV
treatment causing a significant increase in α-diversity. Thus, WG and FV both have the
capability of decreasing inflammation associated with metabolic syndrome, but by
different mechanisms. A follow-up in vitro study was performed using the fecal
microbiota collected from subjects in the WG and refined grain (control) treatment

groups to gain insight into changes in metabolic activity of the microbiota that may help
explain the reduction in inflammatory markers identified in the feeding trial. Microbiota
collected at the end of the WG intervention tended to increase the fermentation of
carbohydrates from WG compared with before the intervention. Correlation analysis
suggested that changes in Corpococcus may be related to increased short chain fatty acids
production by the microbiota and subsequent reduction in inflammatory markers. Thus,
this in vitro approach enabled possible insight into the relationship between WG intake,
changes in the gut microbiota, and reduced inflammation.
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Chapter 1 Introduction
It has been found that both whole grains (WG) and fruit and vegetables (FV) can
reduce markers of metabolic disease, possibly mediated through activity of the gut
microbiota (Martínez et al., 2013; North et al., 2009; Vetrani et al., 2016). However, no
previous studies have compared these two food groups to determine their relative effects
on human health. This thesis is focused on promoting gastrointestinal health and reducing
subclinical inflammation in obese individuals though intake of WG products in
comparison with FV. By comparing WG with FV, observations can be made regarding
which food group may have the most positive impact on health.
Chapter 2 of this thesis reviews research that has been published about WG and
FV. Key foci are clinical WG and FV interventions and epidemiological studies that
address the metabolic benefits of WG and FV.
Chapter 3 of this thesis presents results from a feeding trial comparing the
metabolic effects of consuming the recommended levels of WG or FV in comparison
with refined grains (RG) in an overweight/obese population with habitually low intakes
of WG and FV. The objectives were to 1) perform a 6 week feeding trial with WG, FV
and RG (control) treatments; 2) determine changes in inflammatory markers, fecal
microbiota composition, and microbial metabolite concentrations after treatments; and 3)
determine how changes in inflammatory markers may be related to changes in the gut
microbiota composition during the interventions.
WG and FV have a wide variety of nutritional benefits. Consumption of WG have
shown to decrease inflammatory markers and increase beneficial bacteria in gut bacteria
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(Ampatzoglou et al., 2016; Martínez et al., 2013; North et al., 2009). Epidemiological
studies correlated WG consumption to lowering metabolic type diseases (D. et al., 2003;
McKeown et al., 2009). FV interventions and epidemiological studies have connected FV
to lowering risk of metabolic syndrome through decreased inflammation (Holt et al.,
2009; Mirmiran et al., 2012; Yeon et al., 2012). Based on WG and FV epidemiological
and intervention studies, I hypothesize that the WG intervention will be as effective in
improving beneficial bacteria and reducing subclinical inflammation compared to a FV
intervention, both of which will be better than RG.
Chapter 4 of this thesis describes results from an in vitro fermentation experiment
using stool samples collected from the individuals in the WG and RG treatments at
baseline and at the end of the study. These stool samples were used as a source of gut
bacteria for in vitro fermentation of pre-digested whole wheat flour to determine changes
in carbohydrate fermentation and SCFA production by the microbiota as a result of the
intervention. Previously, others have shown that individuals with higher habitual intake
of plant foods (like WG and FV) harbored a microbiota that was better equipped to
ferment the dietary fibers in WG and produce more butyrate compared with the
microbiota from individuals with lower intake of plant foods (Brahma et al., 2017).
Therefore, I hypothesize that the fecal microbiota collected from subjects after a WG
intervention will be better able to ferment the dietary fibers in whole wheat and produce
butyrate compared with before the intervention.
The final chapter of this thesis includes overall conclusions and prospective
research ideas.
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Chapter 2
Abstract
The importance and benefits of fruits and vegetables (FV) in a healthy diet is well
accepted; however, the importance and benefits of whole grains (WG) are less
recognized. WG and FV clinical interventions have shown to increase beneficial gut
microbiota, increase short chain fatty acid (SCFA) production, and lower antiinflammatory markers. Epidemiological studies have also tied WG and FV to decreasing
anti-inflammatory markers and lowering risks of obesity, metabolic syndrome, and
associated diseases. What is less known is how whole grains, fruit and vegetables are
lowering the risks for metabolic syndrome and such diseases. This review will explain
and compare the key benefits of whole grain, fruit, and vegetables with evidence from
clinical trials and epidemiological studies. The results will show that FV clinical trials
tend to decrease anti-inflammatory markers and through epidemiological studies, WG are
linked to decreased risks for obesity, metabolic syndrome, and associated diseases.
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Introduction
Fruit and vegetables (FV) contain a wide variety of vitamins, minerals, and
polyphenols that can influence human health (Lampe, 1999). A few of these nutrients
include vitamin C, folate, dietary fiber, beta carotene and flavonoids. Different FV have
unique nutritional profiles; therefore, an assortment is recommend to promote health
(Slavin et al., 2012)
FV have been linked to lowering risks of metabolic syndrome by lowering
inflammation. Correlations have been made to explain some interactions between fruit
and vegetable components and inflammatory markers. Within a population of 265
adolescent girls and boys, C-reactive protein (CRP) inversely correlated with intake of
fruit, vitamin C, and folate. Interleukin 6 (IL-6) inversely correlated with intake of
legumes, vegetables, beta carotene, and vitamin C (Holt et al., 2009). CRP and IL-6 are
indicators of inflammation and are markers of increased risk of metabolic diseases
(Marsland, McCaffery, Muldoon, & Manuck, 2010).
Whole grain products contain the germ, endosperm, and pericarp (bran) of the
seeds (Oldways Whole Grains Council, 2017). Whole grains contain dietary fiber,
phytoserols, and vitamin E that have been shown to improve health through lowering
blood cholesterol levels, heart disease, stroke, obesity, and type 2 diabetes (Anderson et
al. 2009; Prasad 2011; Slavin et al., 2012).
There have been numerous feeding trials to investigate the benefits of WG and
FV. Many of these trials focus on individual food groups (vegetables or whole grains),
rather than connecting different food groups. For instance, there are not many published
studies comparing the benefits of WG and FV in a feeding trial. The purpose of this
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review was to investigate the benefits of WG and FV with respect to lowering metabolic
syndrome through inflammatory makers and gut microbiota composition.
Benefits of Fruits and Vegetables
Fruit and Vegetables
There are over 4,000 different fruit and vegetables in the world. The 5 top fruits
consumed in the U.S are bananas, apples, berries, melons, and oranges, and the top 5
vegetables are potatoes, lettuce, onions, tomatoes, and carrots (“Produce for Better Health
Foundation,” 2015). The reference daily intake (RDI) of FV is 5 servings (about ½ c
each) (United States Department of Agricutlure, 2017).
FV have a wide variety of nutrients that can help lower risks of metabolic
syndrome. For instance, vitamin C plays major roles as a cofactor for several enzymes
involved in the biosynthesis of collagen, carnitine, and neurotransmitters, helps
metabolism of cholesterol to bile salts, and helps improve absorption of Fe by keeping it
in its reduced state (Fe2+) (Carr et al.,1999). A cross sectional study was performed on
22,671 adults, and it was found that high intakes (≥85 mg/day) of vitamin C and high
physical activity can lower the risk of metabolic syndrome (Kim et al., 2016).
Flavonoids are phytochemicals found in fruits and vegetables. There are over 20
different flavonoids in fruits and vegetables (Harnly et al., 2006). Flavonoids have been
associated to lower the risk of stroke, coronary heart disease, and markers of
inflammation (Holt et al., 2009). Flavonoids have been shown to decrease plasma
cholesterol, hyperinsulinemia, and blood glucose in diabetic rats (Mulvihill & Huff,
2010).
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Folate consumption has been associated with decreased risk of certain types of
cancer, heart disease, and stroke (United States Department of Health & Human Services,
2016). The RDI of folate is 400 mg/d, which assists with RNA and DNA synthesis and
metabolizing amino acids. In a folic acid supplementation epidemiological study, metaanalysis was able to indicate a 10% lower risk of stroke and 4% lower risk of overall
cardiovascular disease (Y. Li et al., 2016).
On average, fruit or vegetables have about 4 grams of dietary fiber per 100g
depending on the FV (United States Department of Agriculture, 2017a). Depending on
the type of fruit and vegetable the fiber content changes and the ratio of insoluble and
soluble fiber changes as well. The main insoluble fibers in FV are lignin, cellulose, and
xyloglucan, and the soluble fibers are inulin and pectin. Many epidemiological studies
focusing on FV fiber have shown non-significant decreases in metabolic syndrome
related diseases (N. M. McKeown et al. 2009; Rimm EB et al. 1996; Schulze et al. 2007).
Fruit and Vegetables Clinical Trials and Epidemiological Studies
There have been many clinical interventions that investigate the changes in
immune responses and inflammatory markers in response to consuming FV (Table 1). In
a low (1 serving per day) verses high (12 servings per day) fruit and vegetable diet
clinical study, IL-6 was significantly decreased in the high fruit and vegetable diet and
hs-CRP was increased in the low fruit and vegetable diet (Yeon et al. , 2012). This study
also showed that there is a relationship between high fruit and vegetable diet and
lowering lymphocyte DNA damage and proinflammatory cytokine production, which
reduces risks of metabolic diseases. A study where subjects had an option of a wide
variety of 8 servings of FV per day showed a significant decrease in hs-CRP (Watzl et al.,
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2005). In a dietary intervention with 10 g of broccoli sprouts with sulforaphane (225
µmol concentration), the intervention was shown to significantly reduced IL-6 and TNFα and significantly lower hs-CRP (Mirmiarn et al. 2012). In a dietary intervention of wild
blueberry juice (25g wild blueberry powder), it was shown that inflammatory markers
were not significantly decreased but levels of endogenously oxidized DNA bases were
reduced (Riso et al., 2013). These studies suggest that individual fruits and vegetables
could have significant effects on inflammatory markers. These results suggest that people
consuming increased levels of fruits and vegetables could potentially have lower
inflammatory markers, thus, lower chances for inflammatory diseases.
Large scale epidemiological studies have shown the benefits of high FV diets in
reducing inflammatory markers and the risk of chronic disease (Table 3). Holt et al.,
(2009) was able to show inverse correlations between CRP and intake of fruit, vitamin C,
and folate, as well as an inverse relationship between IL-6 with intake of legumes,
vegetables, beta carotene, and vitamin C. The intake of fruit and vegetables has also been
inversely linked to lowering risks of coronary artery disease and certain cancers (Riboli et
al., 2003; Steffen et al. 2003). Clinical trials and epidemiological studies have shown the
significant effects of FV on inflammatory diseases, cancer, and metabolic health.
Benefits of Whole Grains
Whole Grains
The most commonly consumed whole grains are brown rice, wheat, oats, corn,
rye, and barley. The most consumed whole grain products in the U.S are whole wheat
bread, oatmeal, popcorn, whole grain cold cereal, and whole grain pasta (Oldways Whole
Grain Council, 2015.). The current recommendation of whole grains is at least three
servings (1 serving = 1 ounce) per day. Certain whole grains are good sources of dietary
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fiber, vitamin E, and phytosterols (Harvard School of Public Health, 2017). The main
soluble dietary fiber in WG are, ß-glucan, and inulin, and the main insoluble dietary fiber
are cellulose, arabinoxlyan, and lignin.
Arabinoxlyan (AX) is a non-starch polysaccharide that is found in many cereal
grains. It is the one of the most abundant polysaccharides in the cell wall (Mendis et al.,
2016). In the body, purified AX helps control blood glucose and insulin and improved
postprandial metabolic responses (Garcia et al., 2007). Bifidobacterium, Bacteroides, and
Clostridium have shown significant increases in fermenting AX in the gut (Mendis et al.,
2016).
The main source of ß-glucan is in the cell walls of barley and oats. Consuming 3 g
or more ß-glucan per day has been shown to lower cholesterol levels (Anderson et al.,
2009). Other benefits include lowering dyslipidemia, hypertension, and obesity (Khoury
et al., 2012).
Cellulose is an insoluble fiber that acts as a bulking agent that helps move food
through the digestive system. This promotes regular bowel movement and can help
reduce constipation. Cellulose can also be fermented in the gut by Rumminicous (J. et al.,
2013).
One of the notable phytonutrients in whole grains is vitamin E. This antioxidant
can inhibit lipid peroxidation and reactive oxygen species production. One study showed
that vitamin E is linked to lowering CRP levels, which is a marker for inflammation
associated with heart disease. Vitamin E can also lower cholesterol by down regulating
HMG-CoA reductase in cholesterol synthesis (Parsad, 2011).
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Phytosterols are plant based sterols that are a subgroup of steroids. In whole grain
products phyotserols reduce serum cholesterol (Salvin, 2003). They can inhibit dietary
and biliary cholesterol absorption by displacing cholesterol from micelles which
increases excretion. The average western diet includes 200-300 mg/d of plant sterols. The
consumption of whole grains high in phytoserols, rye bread and wheat germ, could
increase phytoserol level in the body. Consumption of 2-3 grams per day of phytoserols
can lower an individual’s LDL by 10% (Mendis et al., 2016).
Whole Grain Clinical Trials and Epidemiological Studies
Although wheat-based food products, even those made with whole grains, have
been implicated as causative agents for obesity, diabetes, and many other diseases in the
popular literature (Davis 2011), scientific studies have found that wheat-based products
lower the risk of type 2 diabetes and cardiovascular disease (Figure 2). Some studies
have investigated the influence of a diet rich in whole grain products on the gut
microbiota composition (Costabile et al., 2008; J. et al., 2013; Martínez et al., 2013).
Intake of high fiber whole grain rye bread and low fiber wheat bread in Finnish adults
during a 12-week intervention decreased Bacteroides vulgatus, Bacteroides plebeius,
and Prevotella tannerae and increased Clostridum cellulosi, Clostridum leptum,
Anaerotruncus colihominis (Lappi et al. 2013). Clinical trial treatments with increased
consumption of whole grain and wheat bran cereals increased Lactobacilli/enterococci
and Bifidobacterium (Costabile et al., 2008). In another 17 week cross over study with
treatments of whole grain, barely, and rice, Bacteroidetes decreased and Firmicutes
increased (Martínez et al., 2013).
Bacterial changes and SCFA production could be impacting anti-inflammatory
markers. Ampatzoglou et al, (2016) showed a significant decrease in IL-10, CRP, and
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insulin with a treatment of 80 grams whole grain per day. Through an intervention of 60
grams of whole gran barely and brown rice, IL-6 was lowered (Martínez et al., 2013).
Numerous epidemiological studies have been completed to investigate the intake
of whole grains with metabolic health (Table 3). Whole grain consumption has been
associated to lower body mass index (BMI), adipose tissue, and obesity (J. Davis,
Alexander, & Ventura, 2009; Nicola M McKeown et al., 2009; van de Vijver, van den
Bosch, van den Brandt, & Goldbohm, 2009). Ma et al. (2008) showed that total intake of
dietary fiber, soluble fiber, and insoluble fiber was inversely related to CRP
concentrations. Lastly, the intake of whole grains and their fibers have been associated
with lower risks of cardiovascular diseases and Type 2 diabetes (D. et al., 2003; Rimm et
al., 2004; M B Schulze et al., 2007). Through clinical interventions and epidemiological
studies whole grains have shown to be associated with to lower metabolic syndrome
through the interactions of gut bacteria fermentation and inflammatory markers.
Comparison of WG and FV Diets
Reviewing FV and WG clinical studies, FV treatments tended to show more
consistent decreases in anti-inflammatory markers (Figure 2.1-2.2). Five out of the eight
FV studies reviewed showed decreases in anti-inflammatory markers with FV treatment.
Two out of the nine WG clinical trials reviewed showed decreases in anti-inflammatory
markers with WG treatment.
The WG treatments tended to show more significant changes in gut microbiota
and production of SCFA. Four studies saw significant changes in gut microbiota. These
changes were seen by increases or decreases in OTUs, increased microbial diversity, and
changes in individual taxa. Five studies had changes in SCFAs or branched chain fatty
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acids (BCFAs). Most studies involving FV did not report changes in gut microbiota and
SCFA production. Only 1 FV study reported changes in the gut microbiota, and this was
an overall bacterial community shift.
Not many intervention studies have shown the relationship between increasing
beneficial bacteria with the link of decreasing anti-inflammatory markers. Martinez et
al., (2013) showed this relationship with a treatment of 60 grams of whole grain barely
and brown rice by an increase in the ratio of Firmicutes/Bacteroidetes, and a change in
abundance of the genus Blautia with a decrease of IL-6. This shows that certain bacteria
could have an impact on lowering anti-inflammatory markers. On the contrary other
studies have shown that Firmicutes/Bacteroidetes do have impacts on certain fibers and
obesity could impact the certain bacteria ratios like Firmicutes/Bacteroidetes (Brandt et
al., 2012; Flint et al., 2012).
Throughout the FV and WG clinical trials there are variable results. Each clinical
trial had a unique treatment to their study. In the FV trials some studies were
investigating certain FV while others were investigating a wide variety of FV. This could
be one of the main causes of their variable results. The WG interventions also had studies
focusing on a particular food option as well as using a wide variety of WG. The
treatments also were giving different levels of whole grains or fiber. All these factors
would be creating the variable results.
Through the reviews of epidemical studies where both whole grain, fruit, and
vegetable intakes were analyzed, WG intake showed more significant relationships with
metabolic syndrome and associated diseases. Five out of the five studies comparing WG
and FV within the same study showed WG intake was more strongly related to reduced
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risks of cancer, obesity, and cardiovascular diseases. Thus, it can be concluded that FV
clinical treatments have shown greater reductions in anti-inflammatory markers, which
help lower metabolic syndrome compared to WG consumption, while epidemiological
studies have linked WG consumption to reduced risk of metabolic disease more so than
FV consumption.

Table 2.1 Review of Clinical Trials with Fruit and Vegetables Interventions
Author
Basu et
al., 2010

Li et al.
2009

Subject
Characteristics
Twenty-seven
subjects with
metabolic
syndrome, 2
males and 25
females; BMI:
37.5±2.15
kg/m2; age:
47.0±3.0y
12 women and
5 men healthy,
nonsmoking
men and
women, 20– 40
y old, and
recruited on the
basis of
GSTM1,
GSTT1, and

Feeding Trial and Treatments
Time periods
options
4 cups freeze-dried
Eight weeks in a
strawberry beverage (50g
randomized
freeze-dried strawberries ~ 3 controlled
cups fresh strawberries in 2
cups water

Randomized,
Total energy,
crossover,
Carbohydrate, Fat,
controlled feeding Protein,
study, 2 14d intake

Significant Results
↓ total and LDLcholesterol, vascular cell
adhesion molecule-1
(VCAM-1),

Overall bacterial
community composition
differed between the 2
consumption periods
Bacterial community was
individual specific in
vegetable diet
↑ Urinary TIC excretion,
fiber consumption
tRFLP fragments that
were significant
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4 diets
1) low-phytochemical basal
diet devoid of fruits
and vegetables and wholegrain, high-fiber foods [major
food items consumed
included bagels, pasta, white
rice, ready-to-eat cereal,
dairy
2) a “single-cruciferous” diet
[i.e. basal diet + 7 g

Not Significant
Results
glucose,
triglycerides, HDLcholesterol, blood
pressure, and waist
circumference,
dietary intake
differences

CYP1A2
genotypes.

Mirmiran
et al. 2012

81 type 2
diabetic
patients,

Ngondi et
al. 2009

102 healthy,
overweight
and/or obese
volunteers

Pierce et
al. 2007

3088 women
previously
treated for early
stage breast
cancer who
were 18 to 70

cruciferous vegetables/(kg
body weight×d)
3) “double-cruciferous diet”
[i.e. basal diet + 14 g
cruciferous vegetables/(kg
body weight×d)
4) a mixed diet [i.e. basal diet
+ 7 g cruciferous
vegetables/(kg body
weight×d) and 4 g apiaceous
vegetables/(kg body
weight×d)
Broccoli sprouts powder
(BSP) with high sulforaphane
concentration
Treatments
1- 10g/d
2- 5g/d
3- placebo
150 mg of IGOB131 (wild
African Mango extract) twice
a day

Telephone counseling
program, cooking classes,
and newsletters targeted to
get participates to consume 5
vegetable servings, 16 oz
vegetable juice, 3 fruit

correlated with double
vegetable Firmicutes,
Bacteroidetes, and
Actinobacteria

Random 4 week Fasting blood
study
glucose

Randomized,
double-blind,
placebo
controlled design
for 10 weeks
Multiinstitutional
randomized
controlled trial of
dietary change

All results were
significant

↑servings of vegetables,
+65%; fruit, +25%; fiber,
+30%, and energy intake
from fat, -13%.
No other significant
changes
24

baseline
demographics,
characteristics of
the original tumor,
baseline dietary
pattern, breast
cancer treatment

↓ C-reactive protein in all
BSP groups
↓ non-significant
decrease in IL-6 ad TNFα between treatment
groups but significant in
group A
↓ C-reactive protein ,
LDL, total cholesterol,
weight, waist, leptin,
Glucose, adiponectin

Riso et al.
2013

Watzl et
al. 2005

years old at
diagnosis
20 Male,
healthy subjects
with at least one
risk factor for
cardio vascular
disease (CVD)
based on
American Heart
Association
guidelines,
needed to
consume2< >5
portions of
FV/day)
Sixty-four
healthy men,
nonsmoker and
didn’t use
dietary
supplements or
medication

servings and 30 g of fiber a
day
WB-25 g of wild blue berry
powder mixed in 250 ml of
water
PL -250 mL water, 7.5 g
fructose, 7 g glucose, 0.5 g
citric acid and 0.03 g
blueberry flavor

1 of 3 treatment groups
1) 2 servings/d
2) 5 servings/d
3) 8 servings/d
Vegetable intake included
carrots, green beans, peas,
broccoli, zucchini, tomatoes,
kohlrabi, Brussels sprouts,
red cabbage, cauliflower,
spinach, corn, and salsifies.
Salad intake included lettuce,
tomatoes, carrots, corn,
radishes, cucumbers, fennel,
and cabbage.

6 week crossover design, 6
week wash out
period

No significant results
besides reducing the
levels of endogenously
oxidized DNA bases

Randomized
Plasma Vitamin C,
longitudinal trial Vitamin E, weight,
of two 4-wk
BMI, energy intake,
treatments
protein, fat,
carbohydrates,
cholesterol, LDL,
HDL, TAG, blood
glucose, IL-2,
interferon, IL-13,
IL-12, TNF-α, NK
cell cytotoxicity
(%) NKp46+, CD3/CD56+, CD3+,
lymphocyte
proliferation

↓ C-reactive protein in
the treatment with 8
servings/d of FV a day
compared with 2
servings/d

25

Vitamin C, folate,
Vitamin B12, blood
pressure, plasma
total nitric oxide
and soluble
vascular cell
adhesion molecule1, weight, BMI,
glucose, TG, LDL,
HDL, IL-6, CRP,
TNF-α

Yeon et
al., 2012

22 overweight
women, nonsmoker and
didn’t use
dietary
supplements or
medication

Fruit intake consisted of
apples, pears, kiwis, bananas,
peaches, nectarines, cherries,
strawberries, and red
currants.
Low FV diet 1 serving of
2 week dietary
fruits and 1 serving of
treatment with a 2
vegetables
week wash out
High FV diet- 6 servings of
fruits and 6 serving of
vegetables The composition
of vegetable and fruit in highVF diet consisted of 2
servings of dark green
vegetable; 2 servings of dark
orange vegetable; 2 servings
of dark red product; 2
servings of other vegetables;
2 servings of vitamin C-rich
fruits/ juices (e.g., orange,
strawberries)

Significant change in
decreasing IL-6 and IL-1
between treatment
groups
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Table 2.2 Review of Clinical Trials with Whole Grains Interventions
Author

Subject
Characteristics
Ampatzo 12 men, 21 women;
glou et
ages 40–65 y, BMI:
al. 2016
20–35 kg/m2,
habitual WG
consumption <24 g/d
Brownlee 316 18-65 years, BMI
et al.
25, consume <30 g
2010
WG/;d

Cooper
et al.,
2017

25 female and 21
male healthy adults;
between the ages of
19 to 46 years with
BMI 20 to 28 kg/m2,
“low whole grain
consumers” < 1
serving of whole

Feeding Trial

Treatments
options
Bread, rice, pasta,
snacks, breakfast
cereals

Time
periods
6 week
cross over
study

Not Significant
Results
IL-1, IL-6, IL-8,
TNFα, CD8+,
ghrelin, GIP, GLP-1,
glucagon, leptin,

Control (no
dietary change),
intervention 1 (60
g WG/d for 16
weeks) and
intervention 2 (60
g WG/d for 8
weeks followed by
120 g WG/d for 8
weeks)

An option of
whole wheat
bread, shredded
wheat, cheerios,
porridge oats,
brown basmati
rice, whole wheat
pasta, weetabix
porridge, oat bar,
chips

16 week
randomized,
controlled
dietary
intervention

Based on
estimated energy
output ex:2000
kcal per day WG 13.7 g fiber/d
RG- 4.2 g fiber/d

Bread, rice, pasta,
snacks, breakfast
cereals, tortilla,
baking mixes

6 week
study
randomized,
controlled
dietary
intervention

Total cholesterol,
HDL, LDL, TAG,
glucose, insulin,
NEFA, QUICKI, RQUICKI, sialic acid,
CRP, IL-6,
fibrinogen, PAI-1,
ICAM-1, VCAM-1,
E-selectin, systolic
BP, diastolic BP,
weight, waist, body
fat percentage
BMI, HDL,
triglycerides,
gastrointestinal
symptoms,
microbiota relative
abundance in a
particular taxa,

WG
High diet- >80
g/day
Low diet-16 g/day

Significant Results
↑ WG Consumption
↑ Fiber intake
↓ IL-10, CRP, insulin, CD4+ T
cells, C-peptide, PAI-1
No changes in biomarkers of
CVC health
↑ WG Consumption
Good compliance

No significant changes in gut
bacteria
↓ LDL, non HDL cholesterol,
fasting blood glucose
↑ bowel movement
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Costabile
et al.
2008

Lappi et
al., 2013

Martinez
et al.,
2013

grains/whole grain
products per day,
32 healthy adults

25 males, 26 females;
40–65 y, a BMI of
26–
39 kg/m2, and at least
3 other features of
metabolic syndrome:
17 females and 11
males healthy adults;
age 25.9±5.5 years

48 g breakfast
cereal
Whole grain
Wheat bran

cereal

Doubleblinded
randomized
crossover
study, 6
week

Feacal SCFA,, fasting
blood glucose,
insulin, total
cholesterol, TAG,
HDL, stool habits

RG- Rye breads
high in fiber
WWB – refined
wheat breads low
in fiber

Breads

randomized,
parallel, 2arm 12-wk
intervention
whether

Intestinal microbiota
composition did not
significantly differ
between the groups,
certain nutrients,

WGB- 60 g of
whole grain barely
BR- 60 g of brown
rice
WGB+BR- 30 g
brown rice, 30 g
of whole grain
barely

Whole grain
barely , Brown
rice

randomized
cross-over
trial with
four-week
treatments

Cholesterol, HDL,
non-HDL, hs-CRP,
LBP, fasting blood
glucose and insulin,
microbial diversity
Chao1,

↑ Bifidobacteria and in whole
grain cereal
↑ Lactobacilli/enterococci with
whole grain and whole bran
cereal
↑ WG Consumption
↑Feurlic acid both treatments
↑ WG Consumption

↓ plasma Androgen receptor

↑ microbial diversity Shannon’s
and Simpson’s indices
↑ Firmicutes, Incertae Sedis
XIV,Blautia, Roseburia,
Bifidobacterium, Dialister
↓ Bacteroridetes,
Bacteriodaceae,
Porphyromonadaceae,
Odoribacter
↓OUT Odoribacter splanchnicus
↑Eubacterium rectale, Roseburia
faecis, Roseburia intestinalis,
Blautia wexlerae, Blautia spp,
Eubacterium rectale
↓ in IL-6 in BR, BR+WGB
treatment groups
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McOrist
et al.
2011

16 males, 30 females;
age 55.9 ± 2.0 y
(range 31–66); body
weight 79.5 6 3.6 kg
(range 57–109).
Illnesses and
participants on
antibiotics were
excluded

Sheflin et
al. 2015

7 adults,
no history of food
allergies or major
dietary restrictions,
not currently taking
cholesterol-lowering
medications or nonsteroidal antiinflammatory drugs
(NSAIDs)

The NSP diet ~25
g of NSP/d- as 50
g BranPlus, 50 g
cooked carrots, 50
g couscous, and 2
g unprocessed
bran
The RS diet
supplement ~22 g
of RS/d - 25 g of
NSP/d as an
extruded, highamylose barley
breakfast cereal,
50 g of a
commercial
canned legume
preparation, 50 g
Greenwheat
Freekeh and 20 g
Hi-maize
SRB-7 meals and
6 snack options
with 30 g/d of
SRB
Non SRB-7 meals
and 6 snack
options with
similar nutrient
content but no
SRB

Carrots, couscous,
bran, barely
breakfast, legume
hi maize, freekeh

randomized
cross-over
study, 4
week

Age, weight, height,
BMI, diet,
propionate, ammonia,
fecal, pH and
moisture

↑ acetate, butyrate, and total
SCFA in RS diet compared to
NSP diet and entry
Fecal butyrate and ammonia
excretions were positively
associated
↑ fecal weight

Meals or snacks
made with heat
stabilized rice bran
(SRB)

four-week,
pilot,
randomizedcontrolled,
singleblinded
dietary SRB
intervention
study

Phyla level bacteria,
SCFA, acetate,
propionate, , valeric,
caproic and heptanoic
acids were

Increases in eight operational
taxonomic units (OTUs),
including three from
Bifidobacterium and
Ruminococcus genera
↑Isovalerate, isobutyrate,
secondary bile acids in SRB
↓Butyrate
Various stool metabolites that
had significant correlations
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Vanegas
et al.
2017

49 men and 32
postmenopausal
women [age range:
40–65 y, BMI from
20 to 35, a report of
the consumption of a
low-fiber diet (men:
,<7 g/1000 kcal;
women: ,8 g/1000
kcal) for >2wk before
enrollment

Meals high in WG
(16 g/1000 kcal)
or RG (8 g/1000
kcal)

Western Style
Meals- high
protein and high
fat

Vetrani
et al.
2016

23 men and 31
women
overweight/obese
with metabolic
syndrome

Whole grain cereal Cereal products
Refined grain
cereal

2 week run
in then 6
week diet

12 week
dietary
intervention

Stool characteristics,
propionate, butyrate,
α and ß-diversity,
relative abundance at
phyla level, IgA,
DTH, IFN, IL-17,
TNF-α, IL-6, TGF-ß,
white blood cells,
lymphocytes,
monocytes,
eosinophils, basophils, or
neutrophils
glucose, BMI,
HOMA, TAG,
cholesterol, HDL,
hs-CRP, IL-1 ra, IL6, and TNF-α, and
SCFAs

WG compared to the RG diet
↑plasma total alkyresorcinols,
stool frequency, Changes in
acetate and total SCFA,
percentage of terminal effector
memory T cells and LPSstimulated ex vivo production of
tumor necrosis factor-a,
Positive correlation between
Lachnospira with acetate and
butyrate
↓ postprandial insulin
↑in fasting plasma propionate
concentrations
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Table 2.3 Review of Epidemiological Studies Associated with FV and WG intake and Metabolic Health
What Investigating

Parameters

Results relating to WG, RG, and FV

Bradlee et
al. 2010

Food group intakes
associated with
central obesity
anthropometry
among children and
adolescents
(covariance
modelling with
PROC GLM)
Diet, lifestyle factors
and telomere length
(change in z score)

3761 children
and 1803
adolescents with
single 24h
dietary recalls
and
anthropometric
measures of
central body fat
2284 female
participants

Adolescents’ central body fat measure were
inversely associated with grain intake.
Central obesity adolescents consumed
significantly less total grains and FV

Dietary fiber intake was positively associated
with telomere length specifically cereal fiber
FV was not significant

WG

Examine fiber
consumption from
fruit, vegetable, and
cereal sources
(including whole
grains and bran) is
associated with
incident CVD in
elderly persons
Changes in dietary
intake with changes
in adiposity and risk
factors for type 2
diabetes
(Partial correlations)

3588 men and
women aged 65
years or older
and free of
known CVD at
baseline

Cereal fiber consumption was inversely
associated with incident CVD. Fruit and
vegetable fiber were not associated with
lowering CVD.

WG

Overweight
Latino youth (n
= 85; aged 11–
17 y)

Increases in total dietary fiber and insoluble
fiber were associated with decreases in visceral
adipose tissue
FV was not tested

WG

Cassidy et
al. 2010

D. et al.
2003

Davis,
Alexander et
al., 2009

Improved
health from
WG or FV
WG
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Study

Holt et al.
2009

285 adolescent
boys and girls,
13-17 yrs

524 subjects, 20
and 70 y

Urinary F2-isoprostane was inversely correlated
with intakes of total fruit and vegetables, vitamin
C, beta carotene, and flavonoids.
CRP was significantly inversely associated with
intakes of fruit, vitamin C, and folate.
IL-6 was inversely associated with intakes of
legumes, vegetables, beta carotene, and vitamin
C.
TNF-α was inversely associated with beta
carotene and lutein.
WG were not tested
Inverse association between intake of total
dietary fiber (separately for soluble and
insoluble fiber) and CRP concentrations in both
cross sectional and longitudinal analyses
FV not tested

FV

WG

434 free-living
adults (177 men
and 257
women) aged
between 60 and
80 y

Cereal fiber was inversely related to BMI, body
fat, and trunk fat mass while fruit and vegetable
fiber were not significant related.

WG

Case-control or
cohort studies
evaluating the

Fruit and vegetables reduce your risk of
esophagus, lung, stomach, and colorectum
cancer.

FV
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Intakes of fruit and
vegetables,
antioxidants, folate,
and total flavonoid
with associated with
markers of
inflammation and
oxidative stress
(Spearman
Correlations
Coefficients)
Ma et al.
Examine longitudinal
2008
associations between
dietary fiber intake
and CRP
(simple linear
regression analysis)
McKeown et Examine the
al. 2009
association between
whole and refined
grain intake and
measures of body fat
distribution and the
relations between
cereal, fruit and
vegetable fiber, and
body fat distribution
(Multivariateadjusted means (95%
CI))
Riboli et al., Examine evidence
2003
from case-control and
prospective studies

on fruit and vegetable
intake and cancer risk
with

Examine the
relationship between
dietary fiber and
risk of coronary heart
disease. (Relative
Risk (95% CI))

Schulze
2007

Examined
associations between
fiber and magnesium
intake and risk of
type 2 diabetes
(Relative Risk (95%
CI))

WG was not tested

A 10-g increase in total dietary fiber was
associated to decreasing your relative risk for
myocardial infarction. When comparing fruit,
vegetable and cereal fiber, cereal fiber was more
associated but not significantly.

WG

Relative risk of Type 2 diabetes was
significantly lowered with cereal fiber. Fruit
lowered RR but not significantly. Vegetable
fiber increased the RR for Type 2 diabetes but
not significantly.

WG
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Rimm EB et
al. 1996

relationship
between total
vegetable and/or
total fruit
consumption
and risk of
cancer
(esophagus,
larynx, stomach,
colon and
rectum, breast,
lung, and
bladder); with
incidence or
mortality as the
endpoint
43 757 US male
health
professionals 40
to 75 years
of age and free
from diagnosed
cardiovascular
disease and
diabetes
completed
9702 men and
15 365 women
aged 35 to 65
years who were
observed for
incident
diabetes

Steffen et al.
2003

van de
Vijver et al.
2009

Examine relations of
whole-grain, refinedgrain, and fruit and
vegetable intakes
with the risk of total
mortality and the
incidence of coronary
artery disease (CAD)
and ischemic stroke
(Multivariateadjusted hazard rate
ratios (and 95% CIs))
Whole grain and
cereal fiber intake
with BMI and risk of
being over weight
(Regression
coefficients )

11 940
participants
(4083 white
men, 4754
white women,
118 8African
American men,
and 1915
African
American
women)

FV intake were inversely associated with
coronary artery disease among the African
American population but not white population.
Whole grains were inversely associated with
total mortality and incident of coronary artery
disease.

FV and WG

2078 men, 2159
women, 55-66
years old, no
cancer

Inverse association between WG consumption
BMI and risk of overweight and obesity
FV was not tested

WG

34
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Chapter 3: Promoting Gastrointestinal Health and Reducing Subclinical
Inflammation in Overweight and Obese Individuals through Intake of Whole Grain
Products in Comparison With Fruits and Vegetables
Abstract
A randomized parallel arm feeding trial was completed on forty-nine overweight
or obese subjects with typically low intake of fruit and vegetables (FV, <2 servings/d)
and whole grains (WG, <1 serving/d). Individuals were randomized into three groups:
WG (3 servings/d; n=17), FV (5 servings/d; n=18), and refined grains (RG; 3 servings/d;
n=14). Treatment foods were incorporated into the subjects’ overall diets. Stool and
blood samples were collected at the beginning of the study and after 6 weeks. In the
blood samples, inflammatory markers [tumor necrosis factor-α (TNF-α), interleukin-6
(IL-6), lipopolysaccharide binding protein (LBP), and high sensitivity C-reactive protein
(hs-CRP)] were measured. Stool sample analysis included short/branched chain fatty
acids (S/BCFA) and microbiota composition. There was a significant decrease in LBP on
both the WG (-0.2 μg/mL, p=0.02) and FV (-0.2 μg/mL, p=0.005) diets, with no change
on the RG diet (0.1 μg/mL, p=0.08). The FV diet induced a significant change in IL-6 (1.5 pg/mL, p=0.006), but no significant change in the other treatments (RG, -0.009
pg/mL, p=0.99; WG, -0.29, p=0.68). The WG diet resulted in a significant decrease in
TNF-α during the intervention (-3.7 pg/mL; p<0.001), whereas no significant effects
were found on the other diets (RG, -0.6 pg/mL, p=0.6; FV, -1.4 pg/mL, p=0.2). The
feeding treatments induced highly individualized changes in microbiota composition such
that treatment group differences were not identified, except for a significant increase in αdiversity in the FV group. These data support the positive impact that WG and FV intake
can have on metabolic health in overweight or obese individuals with normally low
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intake of WG and FV, although it appears that these effects are mediated via different
mechanisms

45

Introduction
Poor diet is the leading risk factor for premature death and disability in the United
States (US Burden of Disease Collaborators, 2013). Poor diets lead to metabolic
syndrome and its associated diseases such as heart disease and diabetes, which rank first
and seventh among common causes of death, respectively (Xu et al., 2012). The health
care cost of treating these chronic diseases is in excess of $600 billion annually (CDC,
2012; CDC, 2014; Mozaffarian et al., 2015). Consequently, the government has directed
policy towards promoting a healthier society, especially to promote healthier eating.
There have been numerous human feeding trials showing that consuming whole
grain (WG) or fruits and vegetables (FV) can have significant impacts on markers of
metabolic syndrome (Martínez et al., 2013; Cooper et al, 2017; Shefin et al, 2015).
Unfortunately, FV and WG intakes are typically far below recommended intake levles
(US Department of Agriculture, USDA 2013). In a typical 2000 kcal diet, the current
recommendations from the USDA are to consume 5 servings of FV and 3 servings of
WG per day. However, in a 2015 report 76% of the US population did not meet the
recommended intake of fruit and 87% did not meet the recommended vegetable intake
(Latetia V. Moore et al., 2015). Over the past 5 years FV consumption has decreased by
7% due to declines in vegetables as a side dish and consumption of juice at breakfast
(Produce for Better Health Foundation, 2015). Likewise, a 2009-2010 survey revealed
that only 2.9% of children/adolescents and 7.7% of adults in the US consumed at least 3
whole grain servings/d (Reicks et al., 2014). The typical American consumes only 1
serving of WG per day (Rehm et al., 2016).
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There are several inflammatory mediators that can be assayed in blood as markers
of metabolic syndrome, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6),
lipopolysaccharide binding protein (LBP), and high sensitivity C-reactive protein (hsCRP). TNF-α is a pro-inflammatory cytokine secreted by macrophages that helps
regulate cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation
(Banday et al., 2017). IL-6 is a pro-inflammatory cytokine that is secreted by
macrophages during infection after trauma to stimulate immune responses (Schafer et al.,
2007). LBP is a protein that is an acute-phase immunologic response to
lipopolysaccharide (Banday et al., 2017). The levels of LBP in blood are a measure of
endotoxemia. hs-CRP is secreted by the liver in response to inflammatory cytokines, and
if most often associated with heart disease risk (Gao et al., 2004).
The metabolic benefits of WG and FV are thought to be mediated, at least in part,
through their interactions with the gut microbiota (Salonen, 2014; Costabile et al., 2008;
Li et al., 2009). One way that the gut microbiota may mediate the anti-inflammatory
effects of dietary fibers is through short chain fatty acid (SCFA) production (Brahe et al
2013), the major metabolic end products of dietary fiber fermentation. These acids are
known to have trophic effects locally on epithelial cell functions as well as distally via
distribution in blood. For instance, SCFA help with maintenance of gut barrier function
by increasing mucin production, inhibiting growth of enteropthogens, and increasing
nutrient absorption. Distally, SCFA are signaling molecules for carbohydrate and lipid
metabolism. SCFA are associated with a decreased risk for cancer and obesity (RíosCovián et al., 2016).
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Typically, human feeding trials confine subjects to a single test food to determine
its benefits on health (Basu et al., 2010; Martínez et al., 2013; Mirmiran et al., 2012;
Sheflin et al., 2015). However, these interventions are not very practical as part of a longterm dietary regimen to improve health. In contrast, Cooper et al., (2017) provided
subjects with a variety of options for treatment foods. Another option is to completely
change someone’s diet to see if certain diets have impacts on metabolic syndrome. The
Mediterranean diet (plant foods like fruit, vegetables, whole grains, legumes and nuts and
replacing vegetable oils with olive oil and canola oil) has been studied to see decreases in
lowering effects of metabolic syndrome (Michalsen et al., 2006; Romaguera et al., 2009).
These studies focus on whole diet changes with counseling on how to cook with these
types of foods. Smaller changes or whole diet changes could be more sustainable for
subjects to continue eating healthy after the study. This purpose of this study was to
determine the impact in participants consuming recommended amounts of whole grains
and fruit and vegetables against a background of their typical diets on inflammatory
makers and gut microbiota composition in overweight or obese individuals that have low
intakes of these food groups.
Materials and Methods
Intervention Study
110 individuals responded to flyers advertising this trial at grocery stores and
University buildings and through social media advertisements. Individuals were screened
during the initial contact period to determine if they qualified for the study and were
interested in participating. Inclusion criteria were: body mass index (BMI) >25 kg/m2, no
diagnosed gastrointestinal diseases, no antibiotic use for 3 months, <1 h/week of
structured exercise, and low intake of FV and WG. BMI was calculated by measuring
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weight and height (in light clothing without shoes). To verify a low intake of FV and
WG, an online validated food frequency questionnaire was used (DHQII, National
Cancer Institute, 2017). The diet survey analyzed participants’ yearly diet and included
questions about serving size. Responses were converted to daily intake of FV or WG
using Diet*Calc software (Bethesda, MD, USA). Sixty one individuals were excluded
due to low BMI, high intake of FV or WG, working out regularly, recent antibiotics use,
health reasons, or scheduling conflicts. Fifty two participants met the inclusion criteria
and were enrolled in the study. Three participants dropped out by the end of the study.
The feeding trial was a randomized parallel arm design. The Institutional Review Board
of the University of Nebraska approved all study protocols described herein (IRB
Approval Number: 20141214525FB). Written informed consent was obtained from all
subjects before being enrolled in the study. The clinical study was posted on
clinicaltrials.gov.
Enrolled subjects were randomized into three groups: WG (3 servings/d; n=17),
FV (5 servings/d; n=18), and refined grains (RG) (3 servings/d; n=14). Participants were
instructed to incorporate these foods into their normal diet. The RG group served as the
control. These subjects were supplied 3 servings/d of RG products to maintain interest
and contact with them during the study; however, all subjects already consumed at least 3
servings/d of RG per day as part of their normal diet. This treatment therefore represented
minimal to no intervention. For the WG and FV treatment groups, 3 servings/d and 5
servings/s were selected because these are the reference daily intakes (RDI)
recommended in the US (United States Department of Agriculture, 2017)
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One week prior to beginning the study and each week during the study
participants visited the clinical facility. During these visits they filled out a “menu” for
the following week. The menu consisted of a list of foods within each treatment group
that the subjects could choose from (Table 1). These foods were commonly available at
the local grocery store. They marked on the menu how many servings of each of the
foods they wanted for the following week. They could choose any combination of any of
the foods on the list, but were required to order at least 21 (WG or RG) or 35 (FV)
servings for the week. They were allowed to order up to 44 servings of FV or 30 servings
of WG per week if they wished.
At all of the weekly visits during the trial period, subjects turned in several daily
diaries that they were required to keep. One diary was a daily diet diary, which included
intake of all test foods. The log consisted of intake of FV, WG, and RG and how many
servings participants consumed. A secondary document was given to participants to
discuss what constituted a serving of grain and FV. The servings from the log were
transferred to an online database that calculated weekly amounts of FV, grains, WG, RG
and other nutrients (United States Department of Agriculture, 2017). This diary was used
to assess compliance to the dietary regimens. Additionally, subjects were asked to
verbally indicate compliance when they visited the facility each week.
Participants also filled out a weekly GI symptom questionnaire (Appendix A.3).
Questions consisted of number of days per week where symptoms were experienced
together with the severity. Symptoms included stomach pains, heart burn, acid reflux,
hunger pains, nausea, rumbling stomach, bloating, burping, flatus, constipation, diarrhea,

50

loose stools, hard stools, urgent bowels, and feeling of incomplete bowel emptying. The
severity was rated on a 0-4 scale (0=no discomfort, slight, mild, moderate, and 4=severe).
Biological Sample Collection and Analysis
Stool and blood samples were collected at the beginning of the study and after 6
weeks. The blood samples were drawn using standard venipuncture techniques by
experienced phlebotomists from the University of Nebraska Medical Center. Blood was
collected into two vacutainer tubes (367815, Vactutainer Serum Tubes, and 367986,
Vacutainer Serum Separation Tubes, BD, Franklin Lakes, NJ USA). About 5 mL was
drawn into each tube. After being collected, samples were left at room temperature for
15-30 min to allow the blood to clot. The samples were then centrifuged (2,000 x g for 10
min). Supernatant (plasma) was aliquoted into smaller test tubes for storage. Tubes were
stored at -80˚C until analysis.
TNF-α and LBP were assayed from the plasma recovered from the Vactutainer
Serum Tubes; IL-6 and hs-CRP were assayed from the plasma recovered from the SST
Serum Separation Tubes. All analyses were carried out using commercial ELISA kits
according to the manufacturer’s instructions (hs-CRP: HU8817; TSZ, Waltham, MA
USA; TNF-α: KHC3011, Invitrogen, Frederick, MD USA; IL-6: HS600B, R&D Systems
Minneapolis, MN USA; LBP: 0628D2100, Sigma Aldrich, St. Louis, MO USA).
Stool samples were collected using a commode collection kit (02-544-208,
Thermo Fischer Scientific, Waltham, MA USA). An insulated cooler with ice packs was
provided to keep samples cool until they could be delivered to the research center for
immediate storage at -20˚ C. The samples were obtained and frozen within 2 h of
defecation
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DNA was extracted using the method described in Martínez et al. (2009). Stool
samples were thawed and 1 g of sample was diluted ten-fold in ice cold phosphate
buffered saline (PBS). Fecal homogenates were transferred into a 2 mL sterile beadbeating tube containing 300 mg of 0.1-mm zirconium beads, and bacterial cells were
collected by centrifugation at room temperature at 8,000 x g for 5 minutes. The bacterial
pellet was washed three times in ice cold PBS. The pellet was resuspended in 0.75 mL of
lysis buffer (200 mM NaCl, 100 mM Tris pH 8.0, 20 mM EDTA) containing 20 mg/mL
of lysozyme (611930010, ACROS Organics) and incubated at 37 °C for 30 min. Eighty
five µL of 10% SBS solution (S0287, Teknova) and 30 µL of proteinase K
(19133,Qiagen) (15mg/mL) was added and then incubated for 15 min at 60 °C. The pellet
was by adding 0.5 mL of phenol:chloroform:isoamyl alcohol (25:24:1) and bead beated
(MiniBeadbeater-8, BioSpec Products, USA) on high for 2 min. In a refrigerated (4 °C)
centrifuge the tube was spun at 10,000 x g for 5 min. The top layer was removed into 1.5
mL tube and 0.5 mL of phenol:chloroform:isoamyl alcohol (25:24:1) was added to the
tube. Then the tube was spun at 10,000 x g for 5 min. The top layer was removed and put
into a new 1.5 mL tube. This step was repeated 3 times followed and each time top layer
was remove into a new 1.5 mL tube. 0.6 mL ethanol was added and then placed in -80°C.
It was then centrifuged at 15,000 rpm for 20 min, whereupon the supernatant was
discarded. The pellet was washed with 0.5 mL of 70% ethanol and was centrifuged at
15,000 rpm for 20 min. The liquid was discarded carefully, and the DNA pellet was dried
for 30 min at room temperature. The DNA was resuspended in 0.1 mL of tris buffer
(10mM, pH8). The DNA pellet was then frozen at -80°C for further experiments.
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Sequencing was performed by University of Minnesota Genomics Center
following the procedure by (Gohl et al., 2016). The V4-V5 region of the 16S rRNA gene
was amplified by PCR using primers Meta_V3_F_Nextera: (5’CCTACGGGAGGCAGCAG-3’)
Meta_V4_806_R: (5’-GGACTACHVGGGTWTCTAAT-3’). PCR reactions are
performed using KAPA HiFidelity Hot Start Polymerase. After the first round of
amplification, PCR 1 products are diluted 1:100 and 5 ul of 1:100 and then ran through a
second PCR. Pooled, size-selected sample was denatured with NaOH, diluted to 8 pM in
Illumina’s HT1 buffer, spiked with 20% PhiX, and heat denatured at 96C for 2 minutes
immediately prior to loading. A MiSeq 600 cycle v3 kit was used to sequence the sample.
Initial Filtering of Low Quality Reads. The base sequence quality information was
confirmed by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). A
stringent quality filter process was applied in which the Illumina sequence reads with (1)
base quality scores below the minimum quality score (30 per base) across the whole read
or (2) read length less than 30 nucleotides were removed using Trim Galore (ver. 0.4.0)
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore). Note that the quality
scores of 30 (Q30) correspond to 0.1% expected base pair call error rates. Also, any
unknown ('N') or ambiguous nucleotide from the Illumina paired-end reads was trimmed.
Quantitative Analysis of the Microbiome Composition. Filtered sequences were
analyzed through the software package QIIME pipeline (ver. 1.9) (Caporaso et al. 2010);
using scripts implemented within QIIME, paired-end reads were merged and were
clustered into operational taxonomic units (OTUs) at a sequence similarity level of 97%
by UCLUST (default parameter). The numerical values of the sequence reads that map to
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OTUs were used to evaluate differences in taxonomic abundance and alpha diversities.
The statistical differences across the samples were determined using DESeq2 (ver. 1.14)
(Love et al., 2014) in the R Bioconductor package (http://www.bioconductor.org) (ver.
3.1.2). OTUs to have less than 10 reads mapped were removed.
Nucleotide sequence accession numbers. All Illumina raw sequences from this study
were deposited in the National Center for Biotechnology Information (NCBI) Sequence
Read Archive (SRA) under accession number pending.
The short chain fatty acid analysis was performed on the fecal samples and
fermented samples based on the procedure described in Pollet et al. (2012) with
modifications. In a 2 ml plastic centrifuge tube that is immersed in ice mix together 0.4
ml of fermented media, 0.1 ml of 7 mM 2-ethylbutyric acid in 2 M potassium hydroxide,
0.2 ml of 9 M sulfuric acid, and 0.16 g of sodium chloride and vortex. In another 2 ml
plastic centrifuge tube that is immersed in ice mix together 0.4 ml water, 0.1 ml of
standard mix in 1 M potassium hydroxide, 0.2 ml of 9 M sulfuric acid, and 0.16 g of
sodium chloride and vortex. Just before injecting onto the GC, add 0.5 ml of diethyl ether
and shake for 30 s to 1 min. Allow layers to separate and transfer diethyl ether layer to a
fresh screw cap microfuge tube with rubber septum. Inject 3-4 μl of diethyl ether phase
using SCFA program on GC.
Statistical Analysis
All data was analyzed using ANOVA (PROC GLIMMIX) where treatment group
was the main factor and BMI (at baseline), gender, and baseline measurement were
covariates using SAS software (version 9.4, SAS Institute, Cary, NC, USA). Differences
among treatments were assessed using Tukey Test; an adjusted P < 0.05 was considered
significant. Changes in measured variables from baseline to the end of the study within
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each group were also assessed after correcting for BMI (at baseline), gender, and baseline
values. The fermentation outcomes (carbohydrates and SCFA) were also analyzed using a
binomial sign test, P < 0.05. Correlations between changes in gut bacteria and changes in
blood parameters and formation outcomes and between changes in diet history and
changes in gut bacteria were analyzed using Pearson correlation (PROC CORR) in SAS
software, P < 0.05.
Results and Discussion
Baseline Data
In the randomized parallel arm feeding study 54 participated and 3 participants
dropped out. There were no significant differences between groups at baseline except in
fecal SCFA (Table 3.2).
Treatment Compliance and Tolerance
Based on diet diaries, participants in the FV and WG groups consumed an average
of 5.7 and 3.4 servings/d of treatment foods, respectively (Table 3.3). This showed that
participants were compliant with the treatment protocol. The diaries also showed that the
interventions were treatment specific; e.g., subjects in the FV group were consuming low
WG foods. Compared to other feeding trials our treatments were very modest in that
subjects consumed the minimum recommendation of that food group. Our study focused
on a sustainable change of the recommended amount of WG or FV with a variety options
in the treatment group. Many participants indicated informally that they planned to
continue trying to consume the recommended amount of FV or WG after the study
period.
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Weekly gastrointestinal symptoms were recorded to track changes throughout the
study. There were no significant changes in GI symptoms throughout the study (Table
3.4).
Plasma Inflammatory Markers
The WG diet resulted in a significant decrease in TNF-α during the intervention,
whereas no significant changes in TNF-α were found on the other treatment groups
(Figure 3.2). Additionally, there was a significant decrease in LBP in the WG and FV diet
with no change on the RG diet. There were no significant changes in the RG and WG
treatments for IL-6, but there was significant decrease in FV diet. There were no
significant changes in hs-CRP.
The WG and FV diets had significant positive impacts on inflammatory markers.
In particular, the change in LBP suggested a positive impact on gut barrier function.
Lipopolysaccharide is a component of the cell walls of gram-negative bacteria; increased
levels of LBP in the blood is suggestive of endotoxemia (Neves et al., 2013) .
The WG diet decreased TNF-α, which was also reported by Qi et al. (2006). In a
study similar to ours, dietary fiber treatment decreased hs-CRP which differs from our
results (North et al., 2009; Qi et al., 2006). In another trial, a treatment of WG rice or
barley lowered the IL-6 in the population (Martínez et al., 2013). The FV diet was the
only treatment that lowered IL-6. A study by Yeon et al., (2012) a FV intervention with a
variety of food options, similar to this study but focusing on high consumption vs small
consumption of FV, were able to significantly reduce IL-6 and IL-1.
Both treatment groups decreased inflammatory markers, but in different ways. FV
decreased IL-6 and TNF-α, and WG decreased LBP and TNF-α. These different changes
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suggest that consuming both FV and WG could have a synergistic effect to help lower
inflammation.
With the variety of food options it is not possible to pinpoint which component of
the foods was responsible for the significant changes in inflammatory markers. Both
treatment groups were good sources of dietary fiber, although the composition of the
dietary fibers within each group are very different. The main dietary fibers in WG are ßglucan, arabinoxlyan, inulin and cellulose, while FV mainly contain pectin, inulin, or
xyloglucan. FV contain more soluble fiber, and WG contain more insoluble fiber
(Dhingra et al, 2012). WG foods can also contribute vitamin E, and phytoserols that have
been linked to lowering parts of metabolic syndrome (Anderson et al., 2009; J. et al.,
2013; Mendiset al., 2016; Salvin, 2003), while FV include folate, flavonoids, vitamin C,
and β-carotene, which have been inversely correlated with hs-CRP and IL-6 (Holt et al.,
2009).
Microbiota
There were no significant changes in fecal short chain fatty acid (SCFA)
production during the study period (Figure 3.3). One study showed a significant increase
in SCFAs when using a more dramatic treatment of high resistant starch (~25 g of NSP/d
as 50 g BranPlus, 50 g cooked carrots, 50 g couscous and 2 g unprocessed bran) (McOrist
et al., 2011). A 3 week treatment of WG cereal showed no significant difference between
whole grain treatment and the control in SCFA production (Costabile et al., 2008), which
compares with our data. SCFA are rapidly absorbed from the gut, which could be why
many studies show no significant changes in SCFA production (Cummings, Pomare,
Branch, Naylor, & Macfarlane, 1987).
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There was a surprising significant increase in BCFAs in the FV treatment (Figure
3.3). This suggests a shift toward protein fermentation by the microbiota. However,
because the subjects in the FV group experienced improvements in metabolic markers
and protein fermentation is associated with negative health outcomes, this is unlikely
(Russell et al., 2011). Perhaps the FV treatment induced changes in the absorption of
BCFA from microbial fermentation.
The Firmicutes were generally higher and Bacteroidetes lower than expected
(Cooper et al., 2017; Vanegas et al., 2017; Sheflin et al., 2015) (Figure 3.5). Similar
studies have shown 20-40% abundance of Bacteroidetes, while this study had 7-11%. The
differences could be due to amplification of different regions of the 16S gene or
differences in DNA extraction protocol. Regardless, there were no significant differences
between treatment groups or from baseline to the end of treatment. Opposing results from
Martínez et al (2013) reported signficiant phylum-level differences in Firmicutes and
Bacteroidetes after feeding 60 g/d of WG, which was generally more dramatic of an
intervention than the present study. An intervention of 14g of cruciferous vegetable was
able to shift overall bacterial community after a 14 day intake period, but no signficant
changes in Firmicutes or Bacteroidetes (Li et al., 2009). The Firmicutes/Bacteroidetes
may not be the best bacteria to investigate since recent reanalyzed data have been
reporting new results that showing different relationships between
Firmicutes/Bacteroidetes and obese populations (Shloss et al., 2016).
There were no significant changes in individual OTUs during the treatment. This
has been previously reported in other WG interventions with a similar experimental
design (Cooper et al., 2017). However, FV interventions and some WG interventions
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have shown changes in individual OTUs belonging to Roseburia and Blautia (Martínez et
al., 2013; Sheflin et al., 2015). When OTUs were binned according to their relative fold
change during the intervention, the WG and FV treatment groups showed a shift toward a
decrease in some OTUs of <0.5-fold while the RG treatment group showed a shift toward
an increase of <0.5 fold (Figure 3.5).
The FV intervention resulted in a significant increase in α-diversity, while the
other treatment groups did not show any differences (Figure 3.5). The wide variety of and
new types of dietary fiber introduced to subjects’ diets in the FV treatment could have
contributed to the increase in bacterial α-diversity in the FV group. In contrast, the WG
diet was mainly composed of wheat-based products which contain similar dietary fibers
to the RG products that subjects consumed as part of their habitual diet prior to the study.
There were no significant changes in ß-diversity over the course of the study
(Figure 3.5). Similar studies (with a wide variety diet) have also shown no significant
differences between treatment groups (Cooper et al., 2017). During a 14 day cruciferous
vegetables intervention there were significant changes in gut bacterial community which
differs from our results (F. Li et al., 2009). Their stricter choice of vegetables could be
aiding these changes.
There were no significant changes in the microbiota at the genus level by
treatment group, but there were individualized responses to the treatments (Figure 3.6).
Other WG and FV interventions have shown similar results of no significant changes at
genus level but individualized changes (Cooper et al., 2017.; J. et al., 2013). On the
contrary Martinez et al., (2013) showed genus level significant changes in Blautia,
Bifidobacterium, and Dialister and Costabile et al., (2008) also saw significant changes in
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Bifidobacterium from a WG intervention. WG diet consisted of mainly wheat based
products. Wheat fibers can have different impacts on the gut bacteria compared to other
whole grain fibers (De Paepe et al., 2017; Duncan et al., 2016).
Conclusions
A FV or WG intervention significantly reduced inflammation, but each diet
induced changes in different markers. The FV treatment decreased IL-6 and LBP and the
WG treatment decreased TNF-α and LBP. Both treatments had individualized effects on
the gut microbiota, with a significant increase in α-diversity in the FV treatment. The data
supports the positive impact that WG and FV intake can have on metabolic health in
overweight or obese individuals with normally low intake of WG and FV, but in different
ways.

Intervention
6 weeks
Overweight
and Obese
subjects
(N=49)

RG Diet Control
(N=14)
FV Diet (5 servings/d)
(N=18)

Run- in
1 week

WG Diet (3 servings/d)
(N=17)

-1

0
Stool and
blood
collected

2

4

6
Stool and
blood
collected

Figure 3.1 Timeline of Experimental Design
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Table 3.1: Food Options During the Treatments
What was
served

Treatment group
Fruit and Vegetables
1 medium
Banana
1 medium
Apple
2
Clementine
½ cup
Strawberries
½ cup
Blueberries
½ cup
Grapes
1 medium
Pear
1 large
Pepper
1 stalk
Celery
½ cup
Broccoli
½ cup
Cauliflower
1 cup
Lettuce
1 cup
Spinach
½ cup
Peas
½ cup
Tomato
½ cup
Carrot
½ cup
Green Beans
Average dietary fiber for 5 servings
Whole grain
1 slice
Whole Wheat Bread
1
tortilla
Whole Wheat Tortilla 14 in
1 tortilla
Whole Wheat Tortilla 7 in
1 package
Oatmeal
1 muffin
English Muffin
¾ cup
Whole Wheat Flakes Cereal
1 package
Ready to Eat Brown Rice
½ cup
Granola
½ cup
Whole Grain Spaghetti
¾ cup
Toasted Oats Cereal
5 crackers
Woven Wheat Crackers
11 biscuits
Shredded Wheat Cereal
Whole Grain Mac and Cheese
Single serving
container
1 bar
Oatmeal Square
1 cup
Popcorn
7-11
chips
Sun Chips
Average dietary fiber for 3 servings
Refined grain
1 slice
White Bread
1 tortilla
Flour Tortilla 7 in

Servings

Dietary fiber
(g/serving)

2
2
2
1
1
1
2
2
1
1
1
1
1
1
1
1
1

3.9
4.4
2.6
2.9
1.8
0.7
5.5
3.4
1.2
1.2
2.1
0.9
1.4
2.3
0.9
2.6
1.4
11.5

0.8
1.9
1
1.7
1.6
1.4
3
1.1
3.5
1.1
1.5
3
0.5

2
5
2
3
3
3
2
7
6
2
3
8
3

0.9
1.25
1.3

2
6
3
11.3

1
1

0
1
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1 tortilla
1 package
1 bagel
2 bagel
¾ cup
1 package
¾ cup
½ cup
¾ cup
5 crackers
1 bar
7-11 chips
Single serving
container
Average dietary fiber for 3 servings

Flour tortilla 14 in
Wheat Farina
Plain Bagel large
Plain Bagel small
Corn Flakes
Ready to eat White Rice
Crispy Rice Cereal
Spaghetti
Rice Flakes Cereal
Buttery Crackers
Crispy Rice Treat
Pita Chips
Mac and Cheese

1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
1.3
0.6
1
1
0
2
0
0
0
1
1
2.2

The serving size for fruit and vegetables is ½ cup. For convenience participants were
given either 1 cup or ½ cup. For instance a whole banana (1 cup) was served due to the
inconvenience of getting a ½ banana and it going bad. FV fiber content was retrieve from
the USDA composition database (United States Department of Agriculture, 2017). The
serving size for whole grains is 1 ounce or 16 grams of whole grain. All servings and
grams of whole grains were calculated by the whole grains food stamp. Some products
more grams of whole grains were given due to convenience like a whole tortilla instead
of a half. Refined grains were serving size was matched whole grain servings. Fiber
serving size was retrieved from nutritional labels of the particular foods.
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Table 3.2. Baseline Data
Baseline data

Groups

BMI
Participants
Female
Male
Inflammatory
Markers
IL-6 (pg/ml)
TNF (pg/ml)

33.4 ± 6.5
17
11
6

Fruit and
vegetables
30.5 ± 5.9
18
12
6

4.4 ± 1.9
26.7 ± 4.17

4.3 ± 2.6
24.2 ± 5.2

2.9 ± 1.5
23.8 ± 5.9

0.5962
0.1105

HS-CRP (mg/ml)

0.8 ± 0.6

0.7 ± 0.4

0.6 ± 0.4

0.8853

LBP (mg/L)

1.9 ± 0.4

1.8 ± 0.4

1.8 ± 0.3

0.3775

Stool Short Chain
Fatty Acids
Acetate

50.4 ± 8.3

45.4 ± 7.6

75.7 ± 8.7

0.0412

Propionate
Butyrate
SCFA
BCFA

11.2 ± 2.1
7.6 ± 1.5
69.3 ± 11.7
1.8 ± 0.3

10.5 ± 1.5
8.4 ± 1.3
64.7 ± 9.8
1.6 ± 0.2

23.8 ± 6.1
18.7 ± 3.4
117.92 ± 17.7
2.4 ± 0.4

0.1379
0.0235
0.0418
0.2419

Whole Grains

Refined Grains

P-Value

30.1 ± 5.2
14
7
7

0.342
0.153
0.153

The serving size for fruit and vegetables is ½ cup. It is recommended to get 5 servings a
day of FV. The serving size for whole grains is 1 ounce or 16 grams of whole grain. It is
recommended to get 3 servings of WG per day. Refined grains were serving size was
matched whole grain servings. This data was analyzed through supertracker
(SuperTracker Home, 2017).

Table 3.3: Average Weekly Intake of Whole Grains, Refine Grains, Fruit, and Vegetables.
Treatment Groups

Average Daily
Intake WG
(servings)

Average Daily Intake
of RG (servings)

Average Daily
Intake of Fruit
(servings)

Average Daily
Average Daily
Intake of Vegetables Intake of FV
(servings)
(servings)

FV

0.9 ± 0.3b

2.4± 0.4b

3.1 ± 0.1a

2.3 ± 0.2a

5.7 ± 0.3a

WG

3.4 ± 0.2a

2.7± 0.7b

0.8 ± 0.1b

0.6 ± 0.1b

1.4 ± 0.2b

RG
0.7 ± 0.1b
7.1 ± 0.7a
1.4 ± 0.1b
0.6 ± 0.2b
2.0 ± 0.2b
The serving size for fruit and vegetables is ½ cup. It is recommended to get 5 servings a day of FV. The serving size for whole grains
is 1 ounce or 16 grams of whole grain. It is recommended to get 3 servings of WG per day. Refined grains were serving size was
matched whole grain servings. This data was analyzed through supertracker (SuperTracker Home, 2017).
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Table 3.4 GI Symptoms Reported at 0, 3, and 6 Weeks of FV, WG, and RG Treatment Groups.
Subjects

Stomach
pains

Heart
Burn

FV
WG
RG

0.33 ± 0.14
0.24 ± 0.14
0.15 ± 0.15

0.17 ± 0.12
0.29 ± 0.19
0.15 ± 0.15

FV
WG
RG

0.5 ± 0.18
0.41 ± 0.17
0.46 ± 0.24

0.56 ± 0.28
0.35 ± 0.21
0.31 ± 0.21

FV
WG
RG

0.33 ± 0.20
0.47 ± 0.19
0.62 ± 0.23

0.22 ± 0.13
0.29 ± 0.16
0.50 ± 0.24

Acid
Hunger Pains
Reflux
Week 0
0.44 ± 0.22
0.77 ± 0.18
0.24 ± 0.14
0.59 ± 0.19
0.58 ± 0.34
0.54 ± 0.22
Week 3
0.17 ± 0.12
0.83 ± 0.19
0.35 ± 0.21
0.71 ± 0.19
0.38 ± 0.27
0.46 ± 0.14
Week 6
0.31 ± 0.15
0.61 ± 0.20
0.06 ± 0.21
0.62 ± 0.23
0.31 ± 0.06
0.59 ± 0.27

Nausea

Rumbling
Stomach

Bloating

0.39 ± 0.20
0.32 ± 0.15
0±0

0.56 ± 0.17
0.38 ± 0.18
0.46 ± 0.13

0.72 ± 0.21
0.44 ± 0.16
0.62 ± 0.24

0.67 ± 0.50
0.24 ± 0.18
0.15 ± 0.15

1.06 ± 0.51
0.74 ± 0.21
0.62 ± 0.24

0.61 ± 0.22
0.74 ± 0.23
0.62 ± 0.29

0.64 ± 0.29
0.24 ± 0.13
0.15 ± 0.15

0.58 ± 0.22
0.62 ± 0.18
0.54 ± 0.24

0.64 ± 0.25
0.47 ± 0.19
0.69 ± 0.24

The significant difference was measured between week 0 and week 6. Severity scale was 0-4, 0 being no discomfort
and 4 being severe. There were significant differences in number of days between bloating and diarrhea. There was no
significant difference between severities. Participates in each group FV=18, WG-17, and RG=14.
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Table 3.4 GI Symptoms reported at 0, 3, and 6 Weeks of FV, WG, and RG Treatment Groups. (Continued)
Subjects

Burping

Flatus

Constipatio
n

FV
WG
RG

0.28 ± 0.18
0.47 ± 0.17
0.15 ± 0.15

1.17 ± 0.25
0.68 ± 0.26
0.38 ± 0.18

0.44 ± 0.25
0.29 ± 0.21
0.5 ± 0.25

FV
WG
RG

0.17 ± 0.09
0.38 ± 0.18
0.31 ± 0.21

1.28 ± 0.25
0.80 ± 0.24
0.62 ± 0.18

0.28 ± 0.19
0.24 ± 0.14
0.15 ± 0.15

FV
WG
RG

0.56 ± 0.40
0.56 ± 0.20
0.15 ± 0.15

0.89 ± 0.23
1.03 ± 0.27
1.23 ± 0.75

0.36 ± 0.17
0.41 ± 0.15
0.23 ± 0.17

Diarrhea

Loose
Stools

Week 0
0.06 ± 0.06 0.44 ± 0.17
0.18 ± 0.10 0.53 ± 0.19
0.54 ± 0.31 0.33 ± 0.26
Week 3
0.61 ± 0.23 0.56 ± 0.23
0.29 ± 0.21 1.00 ± 0.28
0.15 ± 0.15 0.38 ± 0.22
Week 6
0.36 ± 0.19 0.58 ± 0.21
0.35 ± 0.19 0.47 ± 0.19
0.15 ± 0.15 0.23 ± 0.17

Hard Stools

Urgent
Bowels

Not Empty

0.78 ± 0.30
0.44 ± 0.22
0.62 ± 0.29

0.44 ± 0.17
0.76 ± 0.28
0.31 ± 0.31

0.39 ± 0.17
0.47± 0.19
0.46 ± 0.18

0.22 ± 0.17
0.32 ± 0.15
0.77 ± 0.28

1.06 ± 0.27
0.71 ± 0.24
0.54 ± 0.27

0.44 ± 0.18
0.53 ± 0.23
0.62 ± 0.24

0.52 ± 0.24
0.55 ± 0.23
0.46 ± 0.22

0.64 ± 0.19
0.71 ± 0.17
0.23 ± 0.28

0.38 ± 0.18
0.79 ± 0.24
0.70 ± 0.31

The significant difference was measured between week 0 and week 6. Severity scale was 0-4, 0 being no discomfort and 4 being severe. There
were significant differences in number of days between bloating and diarrhea. There was no significant difference between severities. Participates
in each group FV=18, WG-17, and RG=14.
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A

C

B

D

Figure 3.2: Changes in Inflammatory Markers Due to Diet
A- LBP B- TNFα C- hs-CRP D- IL-6 * < 0.05, ** < 0.01, *** < 0.
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B

D

E

E

Figure 2.3: Changes SCFA and BCFA in Fecal Samples
A- SCFA B- BCFA C- Propionate D- Butyrate E- Acetate
67

* < 0.05, ** < 0.01, *** < 0.001

A

B

D

E

C

F

Change in Verrucomicrobia

Change in Firmicutes B- Change in Bacteroidetes C-Change in Proteobacteria D- Change in Verrucomicrobia
E- Change in Actinobacteria F- Change in other Phyla
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Figure 3.4: Changes in Phylum Level Bacteria (Note: No change were significant)
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OTUs (%)

A

50
40
30
20
10
0

RG

WG

FV

log2FoldChange

*

B

C

Figure 3.5 Changes in Gut Microbiota
A-Log2Fold Change of OTUs B- Change in α-Diversity (Shannon’s
Index) C- Weighted Unifrac Distance between Baseline and After
Treatment of ß--Diversity
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Figure 3.6: Heat Map of Log2Fold Change in dominant genera (at least 1 person with an abundance >1%) during the intervention for individual
Participants.
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Chapter 4: In Vitro Fermentation of Pre-digested Whole Wheat Flour with Stool
Samples from an In Vivo Human Feeding Trial with Whole Grains and Refined
Grains
Abstract

Previously, a human feeding trial was conducted on obese and overweight
individual with low intake of whole grains (WG), fruit and vegetables (FV) to investigate
the effects of increasing WG and FV on inflammation markers in the blood and gut
microbiota. The WG treatment found significant decreases in tumor necrosis factor alpha
(TNF-α) and Lipopolysaccharide binding protein (LBP). These decreases could be signs
of improved gut barrier function. The purpose of this study was to use an in vitro
fermentation system to assess the functionality of the fecal microbiota to determine if
changes in microbiota composition and function were associated with changes in
inflammatory markers during the feeding trial. Pre-digested whole wheat flour was
fermented in a batch in vitro fermentation system using stool samples collected before
and after a dietary intervention of whole grains (WG) or refined grains (RG). There were
no significant differences between WG and RG treatment groups for percent fermented
carbohydrate or short chain fatty acid (SCFA) production. Fermentation of non-digestible
carbohydrates in pre-digested whole wheat flour tended to be higher when using the fecal
microbiota collected after the intervention compared with before (p=0.07); however,
there was a high degree of variability among subjects. No change in fermentation of
carbohydrates was evident in the fecal microbiota collected from subjects on the RG
treatment. Correlation analysis among the subjects on the WG intervention showed that
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the change in the relative abundance of Coprococcus was associated with increased
SCFA production and decreased TNF-α and LBP during the intervention. This suggests
that the beneficial effects of the WG intervention on markers of inflammation may have
been due to increased capacity of the gut microbiota to ferment dietary fibers and produce
beneficial SCFAs.
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Introduction
It is difficult to assess the metabolic activity of the human gut microbiota. In vitro
fermentation can be a tool to assess the functionality of the microbiota in terms of its ability
to ferment certain substrates and produce metabolites that are associated with human health
(Smidt etl al., 2009). In a recent study, increased carbohydrate fermentability and butyrate
production came from people consuming higher quality diets compared to low quality diets
(Brahma et al., 2017). Certain bacteria will colonize better with certain fiber; for instance,
inulin is a better substrate for Ruminococcus, Faecalibacterium prausnitzii, and Prevotella
copri, while wheat bran increased Eubacterium xylanophilum and members of
Lachnospiraceae (De Paepe et al., 2017; Duncan et al., 2016).
Quality of diet and particular fibers can alter the gut bacteria, but what is not
known is how these fibers affect gut bacteria and metabolic benefits. Some previous
investigators have used in vitro fermentation to help explain results found in in vivo
studies. Koecher et al., (2014) and Bliss et al., (2013) tried to link the benefits between in
vivo and in vitro, but both studies found that their results were not significantly related to
improved dietary in vitro fermentation through an in vivo supplementation. Daniel et al.
(1997) and Wisker et al. (1998) were able to show that using mixed diet (mixtures of
dietary fibers in intact food) and non-starch polysaccharide (NSP) in vitro can give
sufficient accuracy compared to in vivo testing. When using intact or whole food rather
than individual dietary fibers in vivo and in vitro can be connected to understand the
connection between gut bacteria and metabolic outputs.
Through in vitro fermentation outcomes, correlations can be suggested about diet
and gut bacteria in response to metabolic health. A study analyzed eighteen subjects and
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correlated dietary records with dietary fiber degradation and short-/branched-chain fatty
acid (BCFA) and ammonia production during in vitro fecal fermentation. It was found
that butyrate was correlated with fecal donor intake of some nutrients which were
contributed to grain, nut, and vegetable based foods while BCFA production was
correlated with intake of unsaturated fatty acids (Yang et al., 2014). These types of
correlations help link the relationship between gut bacteria, diet, and human health.
In a previous study, a human feeding trial was conducted on obese and
overweight individuals with low intake of WG, fruit and vegetables FV to investigate the
effects of increasing WG and FV on inflammation markers in the blood and gut
microbiota. Participants consumed 3 servings of whole grains a day or 3 servings of RG a
day. The WG treatment resulted in significant decreases in tumor necrosis factor alpha
(TNF-α) and lipopolysaccharide binding protein (LBP). Presently, an in vitro
fermentation experiment was performed to assess the changes in functionality of the
microbiota following a WG and RG intervention. Correlations were analyzed to examine
relationships between diet, gut microbiota, and fermentation outcomes.
Materials and Methods
Subjects, Dietary Records, and Stool Sample Collection
In chapter 3, dietary records and stool samples were collected from 31
participants from the RG and WG treatment groups. This population had not taken
antibiotics in the last six months, had low intake of FV (<2 servings/d) and WG (<1
serving/d), had a BMI over 25, and did not participate in structured activity. Stool
samples and dietary records were collected as described in chapter 3. All protocols
involving human subjects were approved by the University of Nebraska-Lincoln's Institutional
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Review Board before initiation of the study (no. 20141214525FB) All subjects gave
voluntary informed consent before enrollment in this project.

In Vitro Starch Digestion and Fermentation
Wheat samples (cultivar NW15677) were milled in a Butler mill to separate and
collect bran and flour. Cyclone grinder was used to grind bran to 1 mm, then the flour
and bran was mixed. The milled samples were then subjected to in vitro digestion
according to Yang & Rose 2014.
In vitro batch fermentation was performed based on the procedure described in
Yang & Rose, 2014. Two batch 12 h fermentations were completed using stool samples
at baseline and stool samples after the 6 week intervention. The results from the baseline
fermentation were correlated with subject measurements at baseline. The changes in
fermentation outcomes between the two fermentations were correlated with changes
during the intervention.
Fermentation Analysis
The short chain fatty acid analysis was performed on the fecal samples and
fermented samples based on the procedure described in Pollet et al. (2012). The soluble
and insoluble carbohydrate analysis was performed based on the procedure described in
Arcila et al. (2015).
Statistical Analysis
All data was analyzed using ANOVA (PROC GLIMMIX) where treatment group
was the main factor and BMI (at baseline), gender, and baseline measurement were
covariates using SAS software (version 9.4, SAS Institute, Cary, NC, USA). Differences
among treatments were assessed using Tukey Test; an adjusted P < 0.05 was considered
significant. Changes in measured variables from baseline to the end of the study within
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each group were also assessed after correcting for BMI (at baseline), gender, and baseline
values. The fermentation outcomes (carbohydrates and SCFA) were also analyzed using a
binomial sign test, P < 0.05. Correlations between changes in gut bacteria and changes in
blood parameters and fermentation outcomes and between changes in gut bacteria were
analyzed using Pearson correlation (PROC CORR) in SAS software, P < 0.05. Baseline
diet history was correlated with fermentation outcomes using Spearman partial
correlations with partial variables with energy intake, age, gender, and BMI.
Results and Discussion
Baseline Correlations
Correlations were performed on baseline diet and fermentation outcomes using
the fecal microbiota collected at baseline to determine if subjects’ diets before the study
were associated with in vitro fermentation outcomes (Table 4.1). The correlations
revealed a relationship between carbohydrate quality and SCFA production: diets high in
dietary fiber were associated with higher SCFA production, especially butyrate, whereas
diets high in sugar were associated with reduced SCFA production. “Healthy fat” (ω-3;
polyunsaturated) intake was also positively related to SCFA production during the in
vitro fermentation. Intake of several vitamins and minerals were also correlated with the
SCFA.
These correlations were similar to Yang et al. (2014), but in a different
population. Yang et al. (2014) comprised a generally younger population with lower BMI
while this study included older adults with higher BMI. The median age in this study was
31 and mean BMI was 30, while Yang et al., (2014) had a median age of 24 and median
BMI of 25. Interestingly, although many of the correlations were similar between the two
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groups, production of SCFA, especially butyrate, was much lower in the present
population compared with the previous, healthier population (Figure 4.1).
Correlations were performed between microbiota composition and fermentation
outcomes using baseline fecal samples (Table 4.2). Butyrate showed the most
correlations with microbiota composition, mainly with members of the Firmicutes
phylum. An unclassified genus in the Ruminococaceae family, Faecalibacterium, and
Dialister were highly correlated with SCFA and are known butyrate producers (Brahe et
al., 2013; Scott et al., 2014). Notably, Faecalibacterium abundance was positively
correlated with nearly every fermentation outcome, including the fermentation of the
non-digestible carbohydrate fractions. Unexpectedly, Lachnospira was highly correlated
with SCFA production, including butyrate. Lachnospira are not butyrate producers but
may be important cross-feeding partners with butyrate producers (Cornick et al., 2015).
Two similar studies have found comparable results when looking at changes in
gut microbiota in grain based dietary fiber. Brahma et al. (2017) found Faecalibacterium
was positively correlated with butyrate and Ruminococaceae was negatively correlated
with acetate and SCFA. In another study investigating the in vitro fermentation of six
dietary fibers, Faecalibacterium was positively correlated with SCFA (Yang et al., 2013).
Yang et al. (2013) also had some conflicting results to the present study:
Faecalibacterium was negatively correlated with acetate, and Blautia also had opposite
correlations. The differences in correlations may be due to the different types of
substrates under study.
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Changes in Fermentation Outcomes Using Stool Samples from Before and After the
Intervention
Pre-digested whole wheat flour was fermented in a batch in vitro fermentation
system using stool samples collected before and after dietary intervention. Initially, there
were no significant changes in percent carbohydrate fermented during in vitro
fermentation when comparing before and after each intervention (Figure 4.2). However,
it was evident that there was a high degree of inter-individual variability and, for many
fecal samples from the WG group, the percent carbohydrate fermented at week 6 was
higher than at baseline. Indeed, a binomial sign test indicated that the percent
carbohydrate fermented after the intervention tended to be higher compared with week 0
for individuals in the WG group (p=0.07). Such was not the case for fecal samples
collected from individuals in the RG group (p=0.29). Thus, this suggests that the
microbiota tended to be able to ferment more WG dietary fibers after the intervention
compared to before the intervention.
The % fermentable CHO at baseline is negatively correlated with the change in
fermentable CHO across time points (r=-0.71) (Figure 4.3). This relationship is also true
for butyrate production (r=-0.81). These correlations are not significant for any other
fermentation outcomes. This indicates that people with low ability to ferment CHO (or
produce butyrate) at baseline showed an increase with the WG treatment, while those
with a high capacity to ferment CHO (or product butyrate) at baseline did not improve
further. This is very common. For instance, individuals with very high Bifidobacterium at
baseline typically do not increase further when administered a prebiotic ( Davis et al.,
2011).
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There were no significant differences in SCFA or BCFA production between
fermentations performed using stool samples from week 0 and week 6, regardless of
intervention (Figure 4.5). Brahma et al., (2017) found a significant difference in SCFA
between a high quality diet and a low quality diet. Subjects were divided into groups
based on habitual diet quality. Perhaps the lack of change in the present study is because
the intervention was not long enough or was not severe enough.
Being able to link the results of an in vivo study with the results from an in vitro
has been the subject of a few previous studies. Bliss et al. (2013) found that
supplementation of dietary fibers of psyllium, gum arabic, and carboxymethylcellulose
could not significantly increase degradability of fiber using batch in vitro system. Daniel
et al. (1997) and Wisker et al. (1998) both used mixed intake fiber diets rather than single
fibers as the substrate. When comparing in vivo and in vitro it was found fermentation
outcomes were similar when assaying carbohydrate fermentation from the whole diet.
However, when estimating carbohydrate fermentation from an isolated fiber there were
large differences between in vivo results and in vitro fermentation. Thus, in vitro
fermentation experiments tend to agree well with in vivo outcomes when using intrinsic
and intact dietary fibers as opposed to isolated dietary fibers.
Correlations between changes in fermentation outcomes and inflammatory markers
during the intervention
Correlations were performed on changes in bacteria with the changes in blood
markers and fermentation outcomes of pre-digested wheat flour with the WG treatment.
Changes in only one genus was significantly correlated with both inflammatory markers
that showed significant decreases during the intervention (TNF-α and LBP) and several
fermentation outcomes: Coprococcus (Table 4.3).
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These correlations suggest a connection between changes in gut microbiota
composition (specifically changes in Coprococcus) and function (specifically SCFA
production) during the intervention and reduction in inflammatory markers during the
intervention (Figure 4.6). Corpococcus are gram positive chemoorganotrophs known to
produce butyrate and propionate (Ezaki et al., 2015). A review discussed that microbiotagenerated SCFAs are associated with reduced risk of inflammation (Rial et al.,2016).
Correlations were performed between changes in inflammatory markers, fecal
microbiota, and in vitro fermentation results during the RG intervention (Table 4.4).
Dorea, Bacteroides, Parabacteroides, Oscillopsira, and Dialister had negative
correlations with IL-6. Corobacteriacea, Ruminococcus, and Lactobacillus had positive
correlations with IL-6. Bifidobacterium was negatively correlated with TNF-α,
propionate, and butyrate. Because the RG intervention introduced no dietary intervention
to the subjects and there were no significant changes in inflammatory markers during the
study, the relevance of these correlations may be minimal.
Conclusions
Baseline correlations found that diets high in dietary fiber, ω-3 fatty acids, and
polyunsaturated fatty acids and several vitamins and minerals are associated with higher
SCFA production. It was also found that Ruminococaceae family, Faecalibacterium, and
Dialister are highly correlated with SCFA production during fermentation. After a WG
intervention, the microbiota tended to ferment more CHO after the WG intervention, but
was related to baseline ability of the microbiota to ferment carbohydrates. Such was also
true for butyrate production. Correlations between results from the intervention trial and
the in vitro fermentation suggested a link between changes in the composition and
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function of the microbiota and changes in inflammatory markers. Coprococcus appeared
to play a central role in the production of SCFA during fermentation of carbohydrates and
subsequent reduction in TNF-α and LBP. These data show that in vitro fermentation can
help develop hypotheses explaining the relationship between diet, metabolic health, and
gut bacteria.
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Sat. fat
trans Fat
MUFA
PUFA
ω-3 Fatty acids
Cholesterol
Carbohydrate
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Fructose
Lactose
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Dietary fiber
Soluble fiber
Insoluble fiber
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Animal protein
Plant protein
Vitamin A
Vitamin D
Vitamin E
Vitamin K
Thiamin
Riboflavin
Niacin
Pantothenic acid
Vitamin-B6
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Vitamin B-12
Vitamin C
Ca
Cu
Fe
K
Mg
Mn
Na
P
Se
Zn
Alcohol
Betaine
Caffeine
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Oxalic acid
Phytic acid

Table 4.1 Correlations between results from in vitro fermentation of pre-digested whole wheat flour and habitual nutrient intake of the
fecal donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm., fermented (%); AX, arabinoxylan; N SP, nonstarch polysaccharides; N=31; *p<0.05; **p<0.01.
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uncl_Coriobacteriaceae
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Table 4.2 Correlations between results from in vitro fermentation of pre-digested whole wheat flour and fecal microbiota composition
of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm., fermented (%); cell, cellulose; AX,
arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative abundance >1% are shown; N=31;
*p<0.05; **p<0.01.
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Figure 4.2 Total Carbohydrate Percent Fermentation in vitro Fermentation of Predigested Wheat Flour
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Table 4.3. Correlations between results from in vitro fermentation of pre-digested whole wheat flour with WG treatment, blood
markers, and fecal microbiota composition of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm.,
fermented (%); cell, cellulose; AX, arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative
abundance >1% are shown; N=31; *p<0.05; **p<0.01.
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Table 4.4 Correlations between results from in vitro fermentation of pre-digested whole wheat flour with RG treatment, blood
markers, and fecal microbiota composition of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; fer.,
fermented (%); cell, cellulose; AX, arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative
abundance >1% are shown; N=31; *p<0.05; **p<0.01.
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Chapter 5: Conclusions
Conclusions
Based on whole grain (WG) and fruit and vegetable (FV) epidemiological and
intervention studies, I hypothesized that the WG intervention will be as effective in
improving beneficial bacteria and reducing subclinical inflammation as a FV
intervention, both of which will be better than RG. To test this hypothesis I conducted a 6
week feeding trial with WG, FV, and RG. Inflammatory markers and stool samples were
analyzed before and after the 6 week intervention. The data did support half of my
hypothesis. The WG and FV treatments were effective in reducing subclinical
inflammation compared to the RG treatment. The data did not support the hypothesis that
there were equal treatment effects, but both treatments showed significant decreases in
inflammatory markers. However, their effects may not be equivalent because the markers
that were decreased were different depending on intervention group. Based on differing
effects on inflammatory markers, I now hypothesize that WG and FV are both antiinflammatory but by different mechanisms.
Through in vitro studies from the literature I hypothesized that the fecal
microbiota collected from subjects after a WG intervention will be better able to ferment
the dietary fibers in whole wheat and produce butyrate compared with before the
intervention. The data showed a trend toward higher carbohydrate fermentation after the
WG intervention, but there was a lot of individual variation. There was not a significant
increase in butyrate production. Differences in SCFA production were correlated with
changes in inflammatory markers during the intervention. With these data I now
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hypothesize that the change in Coprococcus improves inflammation by fermenting whole
grain dietary fiber. I also hypothesize that increased SCFA production is responsible for
certain decreases in inflammatory markers.
Changes to the Experiment
The experimental design of this project was fabricated well, but there are slight
changes that could have made the experiment more successful or controlled. Recruiting
participants was a struggle due to finding overweight people who were not trying to get
healthy. Most overweight people either work out or are trying to achieve a healthier diet.
The number of participants was slightly lower than anticipated. By having a larger
sample of participants more changes may have been identified.
The interventions were very modest. Participants could choose from 11-15
different options. In other WG or FV clinical treatments more strict diets and
interventions were enforced (Costabile et al., 2008; J. et al., 2013; Martínez et al., 2013).
With these strict interventions investigators knew exactly what they were eating and
could also correlate individual nutrient components from that food to parameters in the
study. With my interventions I was not able to pinpoint if the change in IL-6 was from a
particular food. Conclusions could only be made that whole grain products or fruit and
vegetable products are making those changes. Future clinical interventions should have
specific food interventions like 1 slice of bread or 1 cup of rice a day.
During the study participants were supposed to continue with their regular diets,
which were already low in whole grains and fruit and vegetables. There was no
restriction on what they could and could not eat besides FV and WG. I assumed that
subjects did not change their normal diet, but there are other foods in the diet (fermented
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products, yogurt, seeds, and certain oils) that can be contributing to changes in gut
microbiota and immune response markers. By not allowing these types of foods maybe
the results would have changed a certain way.
The in vitro fermentation experiment did not show many significant results. The
experiment had a very small sample size, but with a larger sample size potentially more
significance results could be found. The fermentation time could have not been long
enough. In a similar study with a fermentation time of 24 hrs more fermentation and
SCFA production occurred (Brahma et al., 2017). In the in vivo experiment more
dramatic treatments of 5 servings of WG or a single treatment of rye bread could change
more of the functionality of the bacteria for the in vitro fermentation. With a larger
sample size, dramatic intervention, or longer fermentation time potentially more changes
may have been significant.
Future Research
From our results there are different future experiments that can be completed. It
was shown that whole grains and fruit and vegetables decrease inflammation but in
different mechanisms. There could be a synergistic effect happening with these two food
products. I would propose to perform a similar intervention with RG as the control but
have 1 treatment group of participants consuming their RDI of whole grains and fruit and
vegetables to see how inflammation or gut bacteria changes.
Another clinical trial that could be completed is have 6 treatment groups looking
at refined grains, the RDI of whole grains or fruit and vegetables, combining the RDI of
whole grains, fruit and vegetables, and doubling the RDI of whole grains or fruit and
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vegetables. It would be interesting to see how over consumption of WG or FV compares
to control diet and the normal RDI of WG and FV.
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Appendix
Methods
Blood serum was sent to UNL Biomedical and Obesity Research Core (BORC) to
be analyzed for glucose, cholesterol, magnesium, Triglycerides, and HDL using the
Vitros-250 chemistry analyzer.
Results and Discussion
During testing of the plasma markers, it was shown that some of the participants
had elevated glucose levels. This could be from not having a fasting blood sample. Non
fasting blood sample will only effect the plasma markers and should not affect the
inflammatory markers. During the analysis the participants with the evaluated glucose
levels were taken out of the fasting plasma analysis.
As described in Table 1 there were evaluated glucose levels that would affect the
analysis of the fasting blood samples. Figure 1 shows the change in the blood parameters.
There were no significances between treatment groups. This data was very inconclusive
due to the limiting participants that had a low enough glucose level to be considered a
fasting blood sample. A similar study that had a 3 week treatment of whole grain
breakfast cereal showed no significant differences between control and treatment diet in
HDL, cholesterol, and glucose levels.

Table A.1 Baseline Data
Baseline data

Fasting Plasma markers*
Glucose (mg/dL)

Groups
Whole Grains

88 ± 13.75

Fruit and
vegetables

Refined Grains

P-Value

92.29 ± 2.21

92.14 ± 7.13

0.9385

Cholesterol (mg/dL)

170.33 ± 33.50 166.57 ± 29.29

141.71 ± 17.03

0.9676

Magnesium (mg/dL)
Triglycerides (mg/dL)

1.93 ± 0.23
98.33 ± 36.50

1.9 ± 0.15
100.43 ± 28.47

1.79 ± 0.11
74.14 ± 22.87

0.9051
0.6163

HDL (mg/dL)

61.67 ± 10.41

61.86 ± 17.92

52.0 ± 12.62

0.5888

Participants FV=7 WG=3 RG=7.
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A

C

B

D

E

Figure A.1: Changes in Blood Markers Due to Diet
A- Cholesterol B- Glucose C- Magnesium D- Triglycerides E- HDL * < 0.05, ** < 0.01, *** < 0.001
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Table A.2 FV Menu
choose 2 1/2 cups to 3 cups- put either 1, 2 or 1/2 on each day you want that item
Food
Wednesday
Fruit
Banana
Apple
Oranges/ cutie
Strawberries
Grapes
Pear
Veggies
Pepper
Celery
Broccoli
Cauliflower
Lettuce
Spinach
Peas
Tomato
Baby Carrot
Green Beans
max 44 to 42

Thursday Friday Saturday Sunday Monday Tuesday Frozen

1 cup
Fresh Can equivalent
large
large
orange
1 cup
32 grapes

1/2 cup
equivalent
small
medium
cutie
1/2 cup
16 grapes
1 1/2 pear

1 pepper
2 stalks
91 g or 3
spears
107 g
2 cup
2 cup
1 cup

1/2 pepper
1 stalk
45 g
53 g
1 cup
1 cup
1/2 cup
8 cherry
tomato

1 large
12
1 cup

6
1/2 cup
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Table A.3 WG Menu
Choose 3-4 servings per
day
Food
Sara Lee Whole Wheat
Bread
Mission Whole Wheat
Tortilla
Oatmeal
English Muffin
Wheaties Cereal
Ready to Eat Brown Rice
Granola
whole grain Spaghetti
Cheerios Cereal
Triscuit Crackers
Mini Wheats
Mac and Cheese
Oat Bar
Popcorn- Boom Chicka
Pop
Sun Chips
Max 30 servings

Wednesda
y

Thursda
y

Friday Saturday

Sunda
y

Monday

Tuesda
y

Serving size equivalent
to 1
1 slice=1
7 in
1 packet=1
Mini vs Big
3/4 cup
uncle Bens
48 g
1/2 cup=1 serving
3/4 cup
5 chips
11 biscuits
Individual or box
1 square
21 g
7-11 chips
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Table A.4RG Menu
Choose 3-4 servings per
day
Food
Sara Lee White Bread
Mission Flour tortilla
Mission Flour tortilla
Cream of Wheat
Plain Bagel
Corn Flakes
Uncle Bens Ready to eat
White Rice
Rice Krispies Treats
Spaghetti
Special K Cereal
Town House Ritz
Crackers
Rice Krispies
Pita Chips
Mac and Cheese
Max 30 servings per week

Wednesday

Thursday

Friday

Saturday

Sunday

Monday

Tuesday

Serving size equivalent
to 1
1 slice=1
14 in
7 in
1 packet=1
mini vs big
3/4 cup
1 package
1
1/2 cup=1 serving
3/4 cup
25 g
3/4 cup
10-11 chips
box vs individual
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Week
Participant ID
Fill out as accurately as possible. Estimate serving sizes using the serving card provided.
Do not forget condiments, snacks, and beverages.
Date

Meal

Figure A.2: Diet Diary

Item

Amount

Additional information
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Figure A.3 Gastrointestinal Symptom Rating Scale
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Figure A.4 Recruitment Flyer

